Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.48105 | 92 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.6891 | 92 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.5545 | 91 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.35405 | 94 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.73089 | 92 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.77307 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.56964 | 93 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.79035 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.6299 | 92 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.4034 | 91 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.5871 | 92 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.67822 | 92 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.61905 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.56599 | 92 |